Scale-Up Funding Pathway
How a UK scale-up moves from leadership-capability support through to growth equity, consortium R&D, and European programmes.
12
Funding steps
Sequenced for your journey
Curated
Editorial pathway
Months
Typical timeline
Linked
Grants & loans
Funding roadmap
- 1
Standard leadership-capability programme for scaling SMEs.
Step 1 of 12Open grant - 2
- 3
Sector consortium R&D for automotive scale-ups.
Step 3 of 12Open grant - 4
Sector consortium R&D at scale-up stage.
Step 4 of 12Open grant - 5
- 6
European partners and markets via Horizon participation.
Step 6 of 12Open grant - 7
An Innovate UK loan product combined with Investor Partnership equity rounds for late-stage R&D.
Step 7 of 12Open grant - 8
A government-backed co-investment programme designed to support high-growth, R&D-intensive UK companies through large private funding rounds.
Step 8 of 12Open grant - 9
A British Business Bank programme that cornerstones large UK growth-equity fund-of-funds.
Step 9 of 12Open grant - 10
Successor to the Recovery Loan Scheme. A government-backed guarantee enabling accredited lenders to offer term loans, asset finance, invoice finance, overdrafts and revolving credit to UK smaller businesses.
Step 10 of 12Open grant - 11
An Innovate UK service providing free, account-managed innovation and growth advisory support to UK SMEs.
Step 11 of 12Open grant - 12
Innovate UK grants paired with private equity raises through approved investor partners.
Step 12 of 12Open grant
About this pathway
## Quick Answer A UK scale-up — typically post-product-market-fit, £2m–£20m revenue, growing 30%+ year on year — usually layers three funding types: leadership capability (Help to Grow), continued R&D (Smart Grants → ATI → Horizon Europe), and growth equity (British Patient Capital-backed funds). ## Typical Business Profile Established UK businesses past startup risk, with proven revenue, a leadership team, and a credible plan to double or triple in size within 3–5 years. ## Most Realistic First Support - **Help to Grow: Management** — the standard leadership-capability programme used by scaling SMEs. - **Innovate UK Smart Grants** — for ongoing product or process R&D. - **British Patient Capital-backed funds** — when growth equity (rather than venture-style equity) is the right capital structure. ## What Usually Comes Next At the top of the ladder, scale-ups move into **sector consortium funding** (ATI for aerospace, Faraday for battery, Innovate UK challenge funds for digital, energy or life sciences) and **Horizon Europe** participation to access European partners and markets. ## Readiness Signals - 24 months of audited or reviewed accounts showing growth. - A leadership team beyond the founder(s). - A clear capital plan distinguishing grant-fundable R&D from equity-fundable scaling. - Investor-grade governance (proper board, MI pack, KPIs). ## Common Mistakes - Treating grant funding as a substitute for equity at scale-up stage — the maths rarely works. - Underestimating the time cost of consortium-led R&D (ATI, Horizon Europe). - Applying for growth equity without a credible 3-year operating plan. ## Typical Successful Applicant A 5–15 year old UK company with £3m+ revenue, a non-founder CEO or strong COO, a finance lead capable of running an investment process, and a board prepared to govern at scale. ## Related Grants - /grants/help-to-grow-management - /grants/innovate-uk-smart-grants - /grants/ati-programme - /grants/british-patient-capital - /grants/horizon-europe-uk-participation ## Related Comparisons - British Patient Capital vs venture capital (growth equity options) - ATI vs Horizon Europe (consortium R&D at scale)